Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 8, 2026

Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more

View original at seekingalpha.com
Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more [earnings chart] K-Paul/iStock via Getty Images Earnings season continues with another busy, market-moving week ahead, as companies across autos, consumer staples, technology, healthcare, energy, utilities, financials, REITs, and material…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Moderna is transitioning from pandemic-driven revenue toward cost discipline and pipeline execution, with breakeven targeted around 2028

    80% confidence
  • Cleveland-Cliffs has approximately 37% upside over a 12-24-month horizon

    80% confidence
  • Cisco has 14.2% upside potential with $85.9 price target based on 6-7% annual growth from AI infrastructure demand, campus networking upgrades, and network security expansion

    80% confidence
  • Moderna's updated five-year Phase 2b results for intismeran autogene showed a 49% reduction in death or recurrence in melanoma, with potential Phase 3 melanoma and Phase 2 renal cell carcinoma readouts possible in 2026

    80% confidence
  • Despite soft demand, elevated steel prices, and a challenging cost environment, Cleveland-Cliffs stands out as the only U.S. steel producer capable of meaningful balance-sheet and structural transformation

    80% confidence
  • Ford is a classic cyclical stock where upside is capped at current levels and more attractive risk/reward emerges only below $10.50, given pressured margins and constrained earnings leverage

    80% confidence
  • Moderna's preliminary 2025 outlook points to approximately $1.9B in revenue against $5.0B-$5.2B in GAAP operating expenses

    80% confidence
  • Campus networking will see 6-8% industry growth through 2026 via WiFi 7, PoE, and legacy EOL/EOS

    80% confidence
  • Cisco will achieve 50-100bps annual EBIT expansion

    80% confidence
  • Cisco will achieve $3B FY26 AI revenue with >$4B orders from hyperscalers on Silicon One/P200 ramps, and 25%+ optics growth

    80% confidence
  • CSCO blends cyclical and secular strengths for high-single-digit sales and low-teens EPS growth at under 20x P/E versus peers

    80% confidence
  • Airbnb shares trade close to intrinsic value, leaving a limited margin of safety

    80% confidence
  • Cleveland-Cliffs interest burden is expected to exceed $600M this year

    80% confidence
  • Without strategic action, CLF could post a ~$1.3B net loss in 2025, even with supportive steel pricing

    80% confidence

Data points we hold from this source

Ford Motor Company · revenue41.78 billion_USD
Ford Motor Company · vehicle sales2200000 units

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more — Source | Via News | ViaNews Market